Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Equity Income (2016 - 2025)

Historic Equity Income for National Healthcare (NHC) over the last 15 years, with Q3 2025 value amounting to $20.8 million.

  • National Healthcare's Equity Income fell 3643.91% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 9792.65%. This contributed to the annual value of $31.0 million for FY2024, which is 10716.01% up from last year.
  • Latest data reveals that National Healthcare reported Equity Income of $20.8 million as of Q3 2025, which was down 3643.91% from -$5.1 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Equity Income peaked at $32.8 million during Q3 2024, and registered a low of -$25.3 million during Q4 2024.
  • Its 5-year average for Equity Income is $2.3 million, with a median of $3.1 million in 2022.
  • As far as peak fluctuations go, National Healthcare's Equity Income plummeted by 88824.11% in 2021, and later skyrocketed by 115939.22% in 2024.
  • Over the past 5 years, National Healthcare's Equity Income (Quarter) stood at $9.4 million in 2021, then plummeted by 146.21% to -$4.3 million in 2022, then skyrocketed by 377.35% to $12.0 million in 2023, then plummeted by 311.08% to -$25.3 million in 2024, then soared by 182.22% to $20.8 million in 2025.
  • Its Equity Income stands at $20.8 million for Q3 2025, versus -$5.1 million for Q2 2025 and $11.0 million for Q1 2025.